Chemed Corporation $CHE Shares Sold by Hsbc Holdings PLC

Hsbc Holdings PLC cut its holdings in Chemed Corporation (NYSE:CHE) by 69.7% in the fourth quarter, Holdings Channel reports. The institutional investor owned 4,898 shares of the company’s stock after selling 11,265 shares during the quarter. Hsbc Holdings PLC’s holdings in Chemed were worth $2,098,000 at the end of the most recent reporting period.

Other large investors have also made changes to their positions in the company. SG Americas Securities LLC grew its stake in Chemed by 773.5% in the 4th quarter. SG Americas Securities LLC now owns 26,466 shares of the company’s stock valued at $11,324,000 after acquiring an additional 23,436 shares during the period. BNP Paribas Financial Markets raised its position in Chemed by 14.5% during the fourth quarter. BNP Paribas Financial Markets now owns 35,024 shares of the company’s stock worth $14,985,000 after acquiring an additional 4,430 shares during the period. Abacus FCF Advisors LLC purchased a new position in Chemed during the fourth quarter valued at $5,935,000. TD Asset Management Inc lifted its holdings in Chemed by 7.5% during the fourth quarter. TD Asset Management Inc now owns 324,546 shares of the company’s stock valued at $138,860,000 after purchasing an additional 22,715 shares in the last quarter. Finally, C WorldWide Group Holding A S acquired a new stake in shares of Chemed in the fourth quarter valued at about $2,189,000. 95.85% of the stock is owned by institutional investors and hedge funds.

Insider Activity at Chemed

In related news, Director Andrea R. Lindell sold 1,347 shares of the stock in a transaction that occurred on Tuesday, June 9th. The stock was sold at an average price of $447.33, for a total value of $602,553.51. Following the completion of the sale, the director owned 4,578 shares of the company’s stock, valued at approximately $2,047,876.74. This trade represents a 22.73% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Kevin J. Mcnamara sold 2,000 shares of Chemed stock in a transaction that occurred on Friday, May 1st. The stock was sold at an average price of $421.13, for a total value of $842,260.00. Following the transaction, the chief executive officer owned 90,219 shares in the company, valued at approximately $37,993,927.47. The trade was a 2.17% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders own 3.33% of the company’s stock.

Chemed Price Performance

Shares of NYSE CHE traded down $2.70 during mid-day trading on Friday, reaching $487.76. The company’s stock had a trading volume of 143,289 shares, compared to its average volume of 193,784. The stock has a 50-day moving average of $443.16 and a two-hundred day moving average of $428.70. The company has a debt-to-equity ratio of 0.11, a quick ratio of 0.83 and a current ratio of 0.85. The stock has a market capitalization of $6.47 billion, a P/E ratio of 26.58, a P/E/G ratio of 1.80 and a beta of 0.52. Chemed Corporation has a 1-year low of $365.20 and a 1-year high of $493.47.

Chemed (NYSE:CHE) last posted its quarterly earnings results on Thursday, April 23rd. The company reported $5.65 earnings per share for the quarter, topping analysts’ consensus estimates of $5.30 by $0.35. Chemed had a net margin of 10.23% and a return on equity of 27.18%. The firm had revenue of $657.51 million for the quarter, compared to analyst estimates of $659.22 million. During the same period in the previous year, the business posted $5.63 earnings per share. Chemed’s quarterly revenue was up 1.6% on a year-over-year basis. Chemed has set its FY 2026 guidance at 24.000-24.75 EPS. On average, equities research analysts anticipate that Chemed Corporation will post 22.67 EPS for the current fiscal year.

Chemed Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Tuesday, June 16th. Stockholders of record on Thursday, May 28th were issued a dividend of $0.60 per share. This represents a $2.40 annualized dividend and a dividend yield of 0.5%. The ex-dividend date was Thursday, May 28th. Chemed’s payout ratio is currently 13.08%.

Wall Street Analyst Weigh In

A number of analysts have recently commented on the stock. Zacks Research raised shares of Chemed from a “strong sell” rating to a “hold” rating in a research note on Monday, April 27th. Weiss Ratings upgraded Chemed from a “sell (d+)” rating to a “hold (c-)” rating in a report on Wednesday, April 29th. Royal Bank Of Canada boosted their price objective on Chemed from $422.00 to $436.00 and gave the stock a “sector perform” rating in a research note on Monday, April 27th. Wall Street Zen cut Chemed from a “buy” rating to a “hold” rating in a report on Monday, June 8th. Finally, Bank of America raised their target price on Chemed from $450.00 to $510.00 and gave the company a “neutral” rating in a research report on Thursday. One analyst has rated the stock with a Buy rating and five have issued a Hold rating to the company’s stock. According to MarketBeat, Chemed presently has a consensus rating of “Hold” and an average target price of $480.25.

About Chemed

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.